期刊文献+

高糖环境下脂联素对人心肌细胞增殖的影响 被引量:1

下载PDF
导出
摘要 目的体外高糖培养人心肌细胞(HCM)及运用脂联素(ADPN)干预以探讨HCM增殖的影响,以揭示脂联素对高糖环境中的心肌细胞的可能保护作用。方法将HCM分为正常对照组(5.5mmol/L葡萄糖)、高糖组(30.0mmol/L葡萄糖)、脂联素组(30.0mmol/L+2.5μg/mlADPN),分别培养24h、48h、72h,运用MTT测定HCM的增殖情况。结果①在24h高糖组与正常组比较人心肌细胞增殖有促进作用(P<0.05),而高糖组与脂联素组比较没有统计学差异(P>0.05)。48、72h高糖组与正常对照组比较细胞增殖受抑制(P<0.05)。在加入脂联素后48、72h脂联素组与高糖组比较细胞增殖增加,随时间的延长细胞增殖增加明显,有统计学差异(P<0.05)。结论脂联素可以促进HCM增殖,对高糖环境下心肌细胞有保护作用。
作者 张俊洁 李兴
出处 《中国现代药物应用》 2012年第4期45-46,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献7

  • 1Rutz H G, Hanejko F G. High density processing of high performance ferrous materials. In: Terry C M,et al. Advances In Powder Metallurgy & Particulate Materials,1994, 5:117
  • 2Rutz H G, Hanejko F G, Luk S H. Warm compaction of fers high density at low cost. Metal Powder Report, 1994,49 (9) :40
  • 3Braunwald.Heart disease:A Textbook of Cardiovascular Medicine.6thed,2001:2133-2150.
  • 4Capus J M. Die wall lubrication aids higher density. Metal Powder Report, 1998, 53(9):28
  • 5Cao Shunhua, Yi Jianhong, Zhang Lihua, et al. Densification mechanisms and powder mixture designing rules for warm compaction. Journal of Central South University of Technology, 2000, 3(1):4
  • 6Ttudel Y, Gagne M. Compaction behavior of high compressibility low alloy steel powders. Advances in Powder Metallurgy & Particulate Materials, 1989, 1:63
  • 7Chagnon F, Olschewski G, St-Laurent S. Effects of product and process parameters on dimensional stability of sinter hardened materials. Paper presented at the 2001 International Conference on Powder Metallurgy and Particulate Materials, Nice, 2001

共引文献1

同被引文献23

  • 1Fujioka D,Kawabata K,Saito Y,et al .Role of adiponectin receptorsin endothelin induced hypertrophy in cultured cardiomyocytesand their expression infracted heart[J].Am J Physiol HeartCirc Physiol,2006,290:H2409 H2416.
  • 2Liao Y,Takashima S,Maeda N,et al .Exacerbation of heart failurein adiponectin deficient mice due to impaired regulation ofAMPK and glucose metabolism[J].Cardiovasc Res,2005,67:705-713.
  • 3Guzik TJ,Mangalat D,Korbut R.Adipocytokines novel link betweeninflammation and vascular function[J].J Physiol Pharmacol,2006,57:505-528.
  • 4Kadowaki T,Yamauchi T,Kubota N,et al .Adiponectin and adiponectinreceptors in insulin resistance,diabetes,and the metabolicsyndrome[J].J Clin Invest,2006,116:1784-1792.
  • 5Bambace C,Telesca M,Zoico E,et al .Adiponectin gene expressionand adipocyte diameter:A comparison between epicardialand subcutaneous adipose tissue in men[J].Cardiovasc Pathol,2011,20:e153-e156.
  • 6Okada Iwabu M,Yamauchi T,Iwabu M,et al .A small moleculeAdipoR agonist for type 2 diabetes and short life in obesity[J].Nature,2013,503:493-499.
  • 7Hui X,Lam KS,Vanhoutte PM,et al .Adiponectin and cardiovascularhealth:An update[J].Br J Pharmacol,2012,165:574-590.
  • 8Shibata R,Izumiya Y,Sato K,et al .Adiponectin protects againstthe development of systolic dysfunction following myocardial infarction[J].J Mol Cell Cardiol,2007,42:1065-1074.
  • 9Kondo K,Shibata R,Unno K,et al .Impact of a single intracoronaryadministration of adiponectin on myocardial ischemia/reperfusioninjury in a pig model[J].Circ Cardiovasc Interv,2010,3:166-173.
  • 10Fonarow GC,Srikanthan P.Diabetic cardiomyopathy[J].EndocrinolMetabcl in North Am,2006,35:575-599.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部